Compare SVRA & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | LZB |
|---|---|---|
| Founded | 2007 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2009 | 1994 |
| Metric | SVRA | LZB |
|---|---|---|
| Price | $5.05 | $29.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $10.94 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 1.5M | 629.9K |
| Earning Date | 11-11-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 3.27% |
| EPS Growth | N/A | ★ 5.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,349,433,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,963.52 | $3.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.34 | $28.92 |
| 52 Week High | $7.01 | $44.90 |
| Indicator | SVRA | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 29.02 |
| Support Level | $5.16 | N/A |
| Resistance Level | $5.49 | $36.50 |
| Average True Range (ATR) | 0.22 | 0.74 |
| MACD | -0.01 | 0.20 |
| Stochastic Oscillator | 45.11 | 8.60 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.